We are live on
!
Find out more
Denali Therapeutics
DNLI
DNLI
213 hedge funds and large institutions have $3.8B invested in Denali Therapeutics in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 86 increasing their positions, 62 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
39% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 62
7% more first-time investments, than exits
New positions opened: 29 | Existing positions closed: 27
0.08% more ownership
Funds ownership: 69.74% → 69.82% (+0.08%)
0% less funds holding
Funds holding: 214 → 213 (-1)
11% less capital invested
Capital invested by funds: $4.28B → $3.8B (-$480M)
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
77% less call options, than puts
Call options by funds: $2.6M | Put options by funds: $11.3M
Holders
213
Holders Change
-1
Holders Change %
-0.47%
% of All Funds
3.28%
Holding in Top 10
2
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-60%
% of All Funds
0.03%
New
29
Increased
86
Reduced
62
Closed
27
Calls
$2.6M
Puts
$11.3M
Net Calls
-$8.68M
Net Calls Change
-$15.9M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$26.3M |
| 2 |
BlackRock
New York
|
+$26.1M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$20M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$18.8M |
| 5 |
YCM
Yiheng Capital Management
San Francisco,
California
|
+$15.9M |
Top Sellers
| 1 |
PCM
Pathway Capital Management
Irvine,
California
|
-$51.1M |
| 2 |
Goldman Sachs
New York
|
-$30.6M |
| 3 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$20M |
| 4 |
CC
Casdin Capital
New York
|
-$9.48M |
| 5 |
Two Sigma Advisers
New York
|
-$7.18M |
